March 13, 2026 · Form 4 insider transaction
Koenig Sheldon L. bought 723,760 shares of Esperion Therapeutics, Inc. Common Stock at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be June 15, 2026.; Includes 3,930 shares recently acquired in Esperion's Employee Stock Purchase Plan.